Jimenez Freddy A. 4
4 · Celldex Therapeutics, Inc. · Filed Jun 5, 2024
Insider Transaction Report
Form 4
Jimenez Freddy A.
SVP & GENERAL COUNSEL
Transactions
- Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-06-03−8,006→ 27,994 totalExercise: $10.38Exp: 2030-06-18→ Common Stock (8,006 underlying) - Exercise/Conversion
Common Stock
2024-06-03$10.38/sh+8,006$83,102→ 33,930 total - Sale
Common Stock
2024-06-03$33.60/sh−8,006$269,002→ 25,924 total
Footnotes (1)
- [F1]25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.